Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 13 May 2024.Powered by Capital Market - Live News

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held on 7 February 2024, inter alia, have recommended the interim dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs rose 10.65% to Rs 52.76 crore in the quarter ended December 2023 as against Rs 47.68 crore during the previous quarter ended December 2022. Sales declined 4.86% to Rs 448.69 crore in the quarter ended December 2023 as against Rs 471.62 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales448.69471.62 -5 OPM %21.3218.29 - PBDT92.5881.28 14 PBT73.8165.03 14 NP52.7647.68 11 Powered by Capital Market - Live News

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 7 February 2024.Powered by Capital Market - Live News

Net profit of Aarti Pharmalabs rose 1.39% to Rs 51.80 crore in the quarter ended September 2023 as against Rs 51.09 crore during the previous quarter ended September 2022. Sales declined 17.20% to Rs 439.80 crore in the quarter ended September 2023 as against Rs 531.17 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales439.80531.17 -17 OPM %20.0116.90 - PBDT85.0885.41 0 PBT66.9468.84 -3 NP51.8051.09 1 Powered by Capital Market - Live News